AICA riboside prodrugs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 23, A01N 43, A01N, A01N 3170, C07H 1702

Patent

active

050828290

ABSTRACT:
Prodrugs of AICA riboside are provided which increase the bioavailability of AICA riboside and thereby increase extracellular concentrations of the prophylactic and affirmative treatment of various pathologic conditions, including ischemia. Also provided are methods of using AICA riboside prodrugs in treating such conditions.

REFERENCES:
patent: 3910885 (1975-10-01), Moffatt
patent: 4575498 (1986-03-01), Holmes
patent: 4912092 (1990-03-01), Gruber
CA 83(21): 179457t (1975), J. Org. Chem. 40(20) Srivastava "Nucleosides of 4-Substituted Imidazoles".
CA 86(13): 90175p (1976) Chem. Pharm. Bull. 24(9) Miyoshi "Synthesis of 5-Amino-1-(3'-Deoxy-B-D) . . ."
CA 109(19): 170789a (1988) Nucleosides Nucleotides 7(3) chambers "Studies in the Protection & Deprotection . . ."

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

AICA riboside prodrugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with AICA riboside prodrugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and AICA riboside prodrugs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-115668

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.